Session Details
[1S06m]Molecular mechanism of motor neuron disease unravelled: achievements from the interdisciplinary collaboration Support contributed by Kato Memorial Research Grant for Intractable Diseases
Tue. Aug 1, 2023 8:45 AM - 10:45 AM JST
Tue. Aug 1, 2023 11:45 PM - 1:45 AM UTC
Tue. Aug 1, 2023 11:45 PM - 1:45 AM UTC
Room 6 Shirakashi 1
Organizer: Naoki Suzuki (Department of Neurology, Tohoku University Hospital), Aaron Gitler (Department of Genetics, Stanford University)
[1S06m-01]Introduction: Molecular mechanism of motor neuron disease unravelled
○Naoki Suzuki1 (1. Department of Neurology, Tohoku University Hospital)
[1S06m-02]Ribosome profiling and proteomics reveals molecular changes in axons of ALS-patient derived motor nerve organoids.
○Ikeuchi Yoshiho1 (1. The University of Tokyo)
[1S06m-03]The counting method of the number of kinesin-3 motor KIF1A in charge of axonal transport
○Kumiko Hayashi1 (1. ISSP, Univ of Tokyo, Chiba, Japan)
[1S06m-04]Pathophysiological analysis of motor neuron diseases focusing on neuromuscular interactions
○Yohei Okada1 (1. Inst Med Sci Aging, Aichi Med Univ, Aichi, Japan)
[1S06m-05]Free fatty acids support oligodendroglial cell survival in a mouse model of amyotrophic lateral sclerosis
○Rieko Muramatsu1 (1. Nat Inst Neurosci, NCNP, Japan)
[1S06m-06]Recognizing cross-β polymers
○Eiichiro Mori1 (1. Dept Future Basic Med, Sch Med, Nara Med Univ, Kashihara, Japan)
[1S06m-07]Two New ALS Drug Targets (and one Drug)
○Aaron Gitler1 (1. Stanford University)